Literature DB >> 34157824

Voltametric Determination of Zoledronic Acid in a Pharmaceutical Formulation

Abdulaziz Amro1, Samer Ratrout2, Fadi Asfour2.   

Abstract

Objectives: The aim of this study is to study the electroactivity of zoledronic acid (ZOL), optimize the parameters affecting voltametric analysis of ZOL, and make a comparison between voltametric methods used to assay ZOL. Materials and
Methods: Three voltametric methods, cyclic voltammetry (CV), square wave voltammetry (SWV), and differential pulse voltammetry (DPV), were used to determine the concentrations of ZOL solutions (0.25-1.2 mg.mL-1). Britton-Robinson universal buffer solutions (BRB) were used as supporting electrolytes with a glassy carbon working electrode.
Results: The calibration plots were linear in the range from 0.20 to 1.2 mg.mL-1 for differential DPV and CV and from 0.09 to 1.2 mg.mL-1 for SWV. DPV showed the highest correlation coefficient R2 value of 0.993 and the lowest limit of detection (LOD) of 37.2 μg.mL-1. Furthermore, DPV exhibited the highest precision with the lowest relative standard deviations (RSD) values. For a commercial product of ZOL, DPV showed the best accuracy and precision with 102.32% recovery and 2.88% RSD.
Conclusion: ZOL is an electroactive compound. The pH of the BRB supporting the electrolyte is important for ZOL electroactivity. DPV is the recommended method for voltametric analysis of ZOL because of its high-performance regarding accuracy, precision, and LOD compared with other studied methods.

Entities:  

Keywords:  Zoledronic acid; electroanalytical methods; pharmaceutical compound analysis; voltammetry

Year:  2021        PMID: 34157824      PMCID: PMC8231328          DOI: 10.4274/tjps.galenos.2020.97455

Source DB:  PubMed          Journal:  Turk J Pharm Sci        ISSN: 1304-530X


  9 in total

Review 1.  Voltammetric techniques for the assay of pharmaceuticals--a review.

Authors:  Vinod K Gupta; Rajeev Jain; Keisham Radhapyari; Nimisha Jadon; Shilpi Agarwal
Journal:  Anal Biochem       Date:  2010-09-24       Impact factor: 3.365

2.  Development and validation of a highly sensitive RIA for zoledronic acid, a new potent heterocyclic bisphosphonate, in human serum, plasma and urine.

Authors:  Francois Legay; Sonia Gauron; Fabienne Deckert; Ghislaine Gosset; Ulrike Pfaar; Christina Ravera; Hansjörg Wiegand; Horst Schran
Journal:  J Pharm Biomed Anal       Date:  2002-11-07       Impact factor: 3.935

3.  Quantitation of zoledronic acid in murine bone by liquid chromatography coupled with tandem mass spectrometry.

Authors:  Brianne S Raccor; Jianxun Sun; Ross F Lawrence; Lei Li; Hai Zhang; Martha J Somerman; Rheem A Totah
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-07-27       Impact factor: 3.205

4.  Determination of zoledronic acid in human urine and blood plasma using liquid chromatography/electrospray mass spectrometry.

Authors:  Katrin Veldboer; Torsten Vielhaber; Helmut Ahrens; Jendrik Hardes; Arne Streitbürger; Uwe Karst
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-06-01       Impact factor: 3.205

Review 5.  Drugs for the management of osteoporosis: a review.

Authors:  Deepak Kumar Khajuria; Rema Razdan; D Roy Mahapatra
Journal:  Rev Bras Reumatol       Date:  2011 Jul-Aug

6.  Green and cost-effective synthesis of carbon dots from date kernel and their application as a novel switchable fluorescence probe for sensitive assay of Zoledronic acid drug in human serum and cellular imaging.

Authors:  Niloufar Amin; Abbas Afkhami; Leila Hosseinzadeh; Tayyebeh Madrakian
Journal:  Anal Chim Acta       Date:  2018-05-05       Impact factor: 6.558

7.  Development and validation of a method using ultra performance liquid chromatography coupled to tandem mass spectrometry for determination of zoledronic acid concentration in human bone.

Authors:  Alfredo Fabrizio Lo Faro; Raffaele Giorgetti; Francesco Paolo Busardò; Giovanni Lodi; Valeria Martini; Alberto Pispero; Marcello Iriti; Elena Maria Varoni
Journal:  J Pharm Biomed Anal       Date:  2018-09-20       Impact factor: 3.935

8.  Determination of Zoledronic Acid and Its Related Substances by High Performance Liquid Chromatography with Evaporative Light Scattering Detection.

Authors:  Rifat Emre Burmaoglu; Serap Saglik Aslan
Journal:  J Chromatogr Sci       Date:  2019-01-01       Impact factor: 1.618

9.  Prophylactic Effects of Propranolol versus the Standard Therapy on a New Model of Disuse Osteoporosis in Rats.

Authors:  Deepak Kumar Khajuria; Choudhary Disha; Rema Razdan; D Roy Mahapatra; Ramakrishna Vasireddi
Journal:  Sci Pharm       Date:  2013-12-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.